Baxter in $200 million agreement with Corning Clinical Laboratories (CCL)
This article was originally published in Clinica
Executive Summary
A five-year, sole-source supply agreement with Corning Clinical Laboratories is expected to result in $200 revenues for Baxter Healthcare. Products to be provided are laboratory and diagnostic supplies, including Dade International's MicroScan system and haemostasis products. Baxter retained exclusive distribution rights in the US for Dade products when it sold its diagnostic manufacturing division to Bain Capital last year (see Clinica No 624, p 1).